Roban Shabbir

Dr. Roban Shabbir

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JXJacquelyn J. Xu
Jacquelyn J. Xu
BMBrian O. Molokwu
Brian O. Molokwu
Roban ShabbirRoban Shabbir
Roban Shabbir
FCFrançois Boux de Casson
François Boux de Casson
JEJosie Elwell
Josie Elwell
MVMandeep Virk
Mandeep Virk

2 June 2026 in Osteology
Verified
Journal Article
Open access
PDF file
Roban ShabbirRoban Shabbir
Roban Shabbir
SLShums Lareef
Shums Lareef
ZKZion Kang
Zion Kang
BLBrendan Griffin Layton
Brendan Griffin Layton
RHRobert Hoy
Robert Hoy
SRSaqib Rehman
Saqib Rehman
Background/Objectives: Osteoporosis-related fragility fractures are sentinel events that should trigger timely secondary prevention, yet post-fracture care remains inconsistent. Leveraging the NIH All of Us Research Program, we quantified initiation of osteoporosis pharmacotherapy after fragility fracture and explored associations by age, sex at birth, race, and ethnicity. Methods: Retrospective cohort study using All of Us Controlled Tier data (v8) included adults aged 45 to 100 years with an index fragility fracture using prespecified OMOP concept sets intended to capture fractures commonly associated with osteoporosis. A new-user design excluded participants with any osteoporosis pharmacotherapy in the 365 days before fracture; participants required at least 180 days of follow-up. The primary outcome was initiation of osteoporosis pharmacotherapy (bisphosphonates, denosumab, or anabolic agents) within 180 days. Secondary outcomes were completion of dual-energy x-ray absorptiometry (DXA) and bone-health laboratory testing within 180 days. Multivariable logistic regression estimated adjusted odds ratios (OR) for each outcome by age at fracture, sex at birth, race, and ethnicity. Results: Among 1492 eligible participants, 87 initiated pharmacotherapy within 180 days (5.83%). After adjustment, older age was associated with higher odds of initiation (OR 1.04 per year; 95% CI 1.02 to 1.05). Male participants had markedly lower odds of pharmacotherapy initiation (OR 0.20; 95% CI 0.11 to 0.37) and DXA screening (OR 0.22; 95% CI 0.15 to 0.32) compared with female participants. In exploratory adjusted models, we did not detect an independent association between race and pharmacotherapy initiation (White vs. Black/African American OR 1.01; 95% CI 0.49 to 2.09), while White participants had higher odds of DXA screening than Black/African American participants (OR 1.79; 95% CI 1.02 to 3.28). Conclusions: In this diverse national EHR-based cohort, initiation of osteoporosis pharmacotherapy after fracture was uncommon, highlighting a substantial secondary prevention gap. In exploratory adjusted models, male sex was associated with lower odds of pharmacotherapy initiation and DXA receipt, while White participants had higher odds of DXA receipt than Black participants. System-level post-fracture pathways, including fracture liaison services and EHR-based prompts, may improve equitable identification and treatment of osteoporosis for All of Us participants and their communities.

1 December 2025 in Clinics in Shoulder and Elbow
Verified
Journal Article
Open access
PDF file
Roban ShabbirRoban Shabbir
Roban Shabbir
SSSimran Shamith
Simran Shamith
PPPaulo E. L. Parente
Paulo E. L. Parente
LNLuke Nicholson
Luke Nicholson
AAAzad Ali
Azad Ali
Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent neuropathy and about 7% require revision. Type 2 diabetes mellitus (T2DM) worsens ulnar neuropathy, whereas glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be neuroprotective. We compared short- (90-day) and mid-term (2-year) CuTR outcomes in diabetic patients who did or did not receive perioperative GLP-1 RA treatment.Methods: TriNetX identified adults (≥18 years) with T2DM who underwent primary CuTR during the period 2015–2023, and who underwent at least 2 years of follow-up. The experimental cohort had received an active GLP-1 RA prescription at surgery, while the controls had not. Exclusion criteria were T1DM, pancreatitis, multiple endocrine neoplasia 2, systemic steroids, end-stage renal disease, or prior major CuTR. Propensity-score matching (1:1) balanced demographics, body mass index, glycated hemoglobin (HbA1c), creatinine, and comorbidities. Outcomes were captured using International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) and Current Procedural Terminology (CPT) codes.Results: After matching, 1,766 pairs of patients (mean age, 58 years; 46% female) were analyzed. At 90 days, fewer GLP-1 RA users had emergency-department visits than non-users (8.9% vs. 10.7%, P=0.048). Despite higher HbA1c at each timepoint, GLP-1 RA users showed a larger decline. At 2 years, GLP-1 RA exposure was associated with fewer reoperations (5.2% vs. 6.9%, P=0.028), less frequent neuropathy (23.4% vs. 30.4%, P<0.001), and fewer inpatient admissions (14.6% vs. 17.2%, P=0.030). Major medical complications did not differ in occurrence between the groups.Conclusions: Perioperative GLP-1 RA therapy in diabetic patients undergoing CuTR correlated with fewer 90-day emergency visits and lower 2-year risks of revisional surgery and ICD-coded ulnar neuropathy (all-cause, non-adjudicated).. These findings support a potential protective role of GLP-1 RAs in this surgical population. Evidence: III.

10 February 2026 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
MHMegan Hsu
Megan Hsu
RSRyan Stadler
Ryan Stadler
ATAnisha Tyagi
Anisha Tyagi
SSSuleiman Y. Sudah
Suleiman Y. Sudah
JMJoseph E. Manzi
Joseph E. Manzi
GGGlenn Gabisan
Glenn Gabisan

17 September 2025 in Osteoporosis and Sarcopenia
Verified
Journal Article
Open access
Roban ShabbirRoban Shabbir
Roban Shabbir
ZSZubair Shabbir
Zubair Shabbir
PPPaulo E.L. Parente
Paulo E.L. Parente
AAAli Azad
Ali Azad
Vaccine hesitancy threatens global health by diminishing herd immunity and permitting the return of vaccine-preventable diseases (VPDs) including poliomyelitis, measles and coronavirus disease 2019 (COVID-19). These infections carry short-term and long-term musculoskeletal consequences, such as paralysis, limb deformities, septic or reactive arthritis, osteomyelitis and chronic pain, that place an ever increasing burden on orthopaedic services. This narrative review synthesizes clinical and epidemiological evidence linking sub-optimal immunization to orthopaedic morbidity caused by major VPDs.

29 November 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Roban ShabbirRoban Shabbir
Roban Shabbir
EPEmilia Preda
Emilia Preda
HMHarleen K. Multani
Harleen K. Multani
TATioluwa Akinjaiyeju
Tioluwa Akinjaiyeju
SGShaina Gagadam
Shaina Gagadam
JBJulia Burger
Julia Burger
Pediatric burn evaluation is often subjective; early estimates of depth and TBSA% drive triage, surgery, and follow-up. Emerging artificial intelligence (AI) tools, especially image-based methods, aim to standardize assessment and extend expertise via telemedicine. To narratively review AI applications relevant to pediatric burn care across diagnosis (depth/healing), TBSA% estimation, treatment planning/monitoring, telemedicine, and rehabilitation, and to summarize practical and ethical considerations for translation. Narrative review of PubMed/MEDLINE and Embase (January 2000-June 2025) with citation chaining. Pediatric and mixed-age studies applicable to pediatric care were included; conference abstracts and preprints were excluded unless subsequently published. Heterogeneity precluded quantitative synthesis; results are qualitatively summarized. Evidence is strongest for image-based assessment (clinical photographs, multispectral/optical modalities) supporting depth/healing classification and TBSA% segmentation, with several studies showing promising discrimination compared with unaided clinical assessment. Telemedicine workflows for remote triage and follow-up appear feasible, while data-driven decision support for timing of surgery and advanced dressing strategies remains investigational. Pediatric-specific datasets, external validation against accepted comparators, and reporting across skin tones and ages are still limited. AI has the potential to complement clinician judgment in pediatric burn care, most immediately for early image-based assessment and remote follow-up. Broader adoption will require pediatric-focused datasets, rigorous external validation, transparent governance for privacy and bias, and clear human-in-the-loop oversight.